About this data
What it is
The FDA publishes its decisions on drugs and medical devices through openFDA. We list approved drug applications and the changes approved to them, 510(k) clearances of devices and premarket approvals (PMA) of higher-risk devices, and match the applicant to a public company when the name lines up. The page opens on new brand-name drugs and biologics: the first approval of a new drug application (NDA) or biologics license application (BLA).
Who files it
The FDA decides; openFDA publishes the FDA's records. The applicant is the company named in the FDA's record for the application.
How current
We check openFDA every day. The FDA refreshes its files on its own schedule, and a decision can appear days to weeks after its date, so the latest approvals may show up late.
Terms
openFDAopenFDA is the FDA's public data service. It publishes the FDA's own records of drug approvals and device decisions. openFDA asks users not to imply that the FDA endorses their product or service: this site is not endorsed by or affiliated with the FDA.NDA and BLAA new drug application (NDA) asks the FDA to approve a drug made from chemicals. A biologics license application (BLA) asks for a biologic, such as an antibody or a vaccine. The first approval is the original.supplementA later approved change to a drug that is already on the market: a new use, a new dose, a label change or a manufacturing change. Many supplements are minor.generic drugsA generic drug (an ANDA, or abbreviated new drug application) is approved because it matches a drug already on the market. Generics are made by many companies, most of which are not public.510(k)A device maker shows the FDA that its device is substantially equivalent to one already sold. The FDA clears it, which is a lighter review than an approval.PMAPremarket approval: the FDA's strictest review, for higher-risk devices. The maker must show the device is safe and effective.company matchWe match the applicant's name to a public company automatically, and by hand for the large drugmakers. Most applicants, such as generic makers and private device makers, do not match, and a subsidiary or a differently spelled name can be missed.
Worth knowing
This is a record of decisions already made. It is not a calendar of coming decisions: a drug under review does not appear, and we show no review dates. openFDA asks users not to imply that the FDA endorses their product or service: this page is not endorsed by or affiliated with the FDA, and the FDA makes no warranty about the data. It is not for medical decisions. Most applicants, such as generic makers and private device makers, do not match a public company, and a subsidiary or a differently spelled name can be missed, so a row with no ticker may still belong to one. A clearance is not an approval, and many approved supplements are minor.
Not to be confused with
Clinical trial updates: what sponsors report about their studies, not what the FDA decided.

All of this comes from openFDA, the FDA's public data service. This site is not endorsed by or affiliated with the FDA.

FDA decisions per day, last 30 days

010203040Oct 17 · Brand-name drugs and biologics, with supplements: 0Oct 17 · Device clearances and approvals: 0Oct 17Oct 18 · Brand-name drugs and biologics, with supplements: 0Oct 18 · Device clearances and approvals: 1Oct 19 · Brand-name drugs and biologics, with supplements: 4Oct 19 · Device clearances and approvals: 10Oct 20 · Brand-name drugs and biologics, with supplements: 3Oct 20 · Device clearances and approvals: 12Oct 21 · Brand-name drugs and biologics, with supplements: 6Oct 21 · Device clearances and approvals: 18Oct 21Oct 22 · Brand-name drugs and biologics, with supplements: 6Oct 22 · Device clearances and approvals: 15Oct 23 · Brand-name drugs and biologics, with supplements: 7Oct 23 · Device clearances and approvals: 24Oct 24 · Brand-name drugs and biologics, with supplements: 0Oct 24 · Device clearances and approvals: 1Oct 25 · Brand-name drugs and biologics, with supplements: 0Oct 25 · Device clearances and approvals: 1Oct 25Oct 26 · Brand-name drugs and biologics, with supplements: 4Oct 26 · Device clearances and approvals: 17Oct 27 · Brand-name drugs and biologics, with supplements: 5Oct 27 · Device clearances and approvals: 18Oct 28 · Brand-name drugs and biologics, with supplements: 2Oct 28 · Device clearances and approvals: 15Oct 29 · Brand-name drugs and biologics, with supplements: 3Oct 29 · Device clearances and approvals: 27Oct 29Oct 30 · Brand-name drugs and biologics, with supplements: 6Oct 30 · Device clearances and approvals: 32Oct 31 · Brand-name drugs and biologics, with supplements: 0Oct 31 · Device clearances and approvals: 0Nov 1 · Brand-name drugs and biologics, with supplements: 0Nov 1 · Device clearances and approvals: 0Nov 2 · Brand-name drugs and biologics, with supplements: 1Nov 2 · Device clearances and approvals: 0Nov 2Nov 3 · Brand-name drugs and biologics, with supplements: 1Nov 3 · Device clearances and approvals: 0Nov 4 · Brand-name drugs and biologics, with supplements: 3Nov 4 · Device clearances and approvals: 0Nov 5 · Brand-name drugs and biologics, with supplements: 2Nov 5 · Device clearances and approvals: 0Nov 6 · Brand-name drugs and biologics, with supplements: 4Nov 6 · Device clearances and approvals: 0Nov 6Nov 7 · Brand-name drugs and biologics, with supplements: 0Nov 7 · Device clearances and approvals: 0Nov 8 · Brand-name drugs and biologics, with supplements: 0Nov 8 · Device clearances and approvals: 0Nov 9 · Brand-name drugs and biologics, with supplements: 5Nov 9 · Device clearances and approvals: 0Nov 10 · Brand-name drugs and biologics, with supplements: 5Nov 10 · Device clearances and approvals: 0Nov 10Nov 11 · Brand-name drugs and biologics, with supplements: 1Nov 11 · Device clearances and approvals: 0Nov 12 · Brand-name drugs and biologics, with supplements: 0Nov 12 · Device clearances and approvals: 0Nov 13 · Brand-name drugs and biologics, with supplements: 0Nov 13 · Device clearances and approvals: 0Nov 14 · Brand-name drugs and biologics, with supplements: 0Nov 14 · Device clearances and approvals: 0Nov 14Nov 15 · Brand-name drugs and biologics, with supplements: 0Nov 15 · Device clearances and approvals: 0
010203040Oct 17 · Brand-name drugs and biologics, with supplements: 0Oct 17 · Device clearances and approvals: 0Oct 17Oct 18 · Brand-name drugs and biologics, with supplements: 0Oct 18 · Device clearances and approvals: 1Oct 19 · Brand-name drugs and biologics, with supplements: 4Oct 19 · Device clearances and approvals: 10Oct 20 · Brand-name drugs and biologics, with supplements: 3Oct 20 · Device clearances and approvals: 12Oct 21 · Brand-name drugs and biologics, with supplements: 6Oct 21 · Device clearances and approvals: 18Oct 21Oct 22 · Brand-name drugs and biologics, with supplements: 6Oct 22 · Device clearances and approvals: 15Oct 23 · Brand-name drugs and biologics, with supplements: 7Oct 23 · Device clearances and approvals: 24Oct 24 · Brand-name drugs and biologics, with supplements: 0Oct 24 · Device clearances and approvals: 1Oct 25 · Brand-name drugs and biologics, with supplements: 0Oct 25 · Device clearances and approvals: 1Oct 25Oct 26 · Brand-name drugs and biologics, with supplements: 4Oct 26 · Device clearances and approvals: 17Oct 27 · Brand-name drugs and biologics, with supplements: 5Oct 27 · Device clearances and approvals: 18Oct 28 · Brand-name drugs and biologics, with supplements: 2Oct 28 · Device clearances and approvals: 15Oct 29 · Brand-name drugs and biologics, with supplements: 3Oct 29 · Device clearances and approvals: 27Oct 29Oct 30 · Brand-name drugs and biologics, with supplements: 6Oct 30 · Device clearances and approvals: 32Oct 31 · Brand-name drugs and biologics, with supplements: 0Oct 31 · Device clearances and approvals: 0Nov 1 · Brand-name drugs and biologics, with supplements: 0Nov 1 · Device clearances and approvals: 0Nov 2 · Brand-name drugs and biologics, with supplements: 1Nov 2 · Device clearances and approvals: 0Nov 2Nov 3 · Brand-name drugs and biologics, with supplements: 1Nov 3 · Device clearances and approvals: 0Nov 4 · Brand-name drugs and biologics, with supplements: 3Nov 4 · Device clearances and approvals: 0Nov 5 · Brand-name drugs and biologics, with supplements: 2Nov 5 · Device clearances and approvals: 0Nov 6 · Brand-name drugs and biologics, with supplements: 4Nov 6 · Device clearances and approvals: 0Nov 6Nov 7 · Brand-name drugs and biologics, with supplements: 0Nov 7 · Device clearances and approvals: 0Nov 8 · Brand-name drugs and biologics, with supplements: 0Nov 8 · Device clearances and approvals: 0Nov 9 · Brand-name drugs and biologics, with supplements: 5Nov 9 · Device clearances and approvals: 0Nov 10 · Brand-name drugs and biologics, with supplements: 5Nov 10 · Device clearances and approvals: 0Nov 10Nov 11 · Brand-name drugs and biologics, with supplements: 1Nov 11 · Device clearances and approvals: 0Nov 12 · Brand-name drugs and biologics, with supplements: 0Nov 12 · Device clearances and approvals: 0Nov 13 · Brand-name drugs and biologics, with supplements: 0Nov 13 · Device clearances and approvals: 0Nov 14 · Brand-name drugs and biologics, with supplements: 0Nov 14 · Device clearances and approvals: 0Nov 14Nov 15 · Brand-name drugs and biologics, with supplements: 0Nov 15 · Device clearances and approvals: 0

Brand-name drugs and biologics, with supplements Device clearances and approvals

By the FDA's decision date. Generic drugs are left out. The FDA's files can lag a decision by days to weeks, so the most recent days fill in later.

Latest FDA decisions

Reset

Showing: ticker ANGO · Everything

Latest FDA decisions
DecidedProductApplicantWe match the applicant's name to a public company automatically, and by hand for the large drugmakers. Most applicants, such as generic makers and private device makers, do not match, and a subsidiary or a differently spelled name can be missed.DecisionA new drug application (NDA) asks the FDA to approve a drug made from chemicals. A biologics license application (BLA) asks for a biologic, such as an antibody or a vaccine. The first approval is the original. A device maker shows the FDA that its device is substantially equivalent to one already sold. The FDA clears it, which is a lighter review than an approval. Premarket approval: the FDA's strictest review, for higher-risk devices. The maker must show the device is safe and effective.FDA page
Oct 30, 2026AngioVac F1885ANGO
AngioDynamics, Inc.
Device clearance (510(k))
Traditional
K263076 ↗
Mar 24, 2026NanoKnife Generator (H78720300351US0)ANGO
Angiodynamics
Device clearance (510(k))
Traditional
K253198 ↗
Nov 24, 2025AlphaVac Multipurpose Mechanical Aspiration System F1885ANGO
AngioDynamics, Inc.
Device clearance (510(k))
Traditional
K252509 ↗
Oct 24, 2025AngioVac CannulaANGO
AngioDynamics, Inc.
Device clearance (510(k))
Special
K253106 ↗
Dec 6, 2024NanoKnife Generator (H78720300301US0); NanoKnife Single Ele…ANGO
AngioDynamics, Inc.
Device clearance (510(k))
Traditional
K242687 ↗
Apr 1, 2024AlphaVac MMA F1885 System (H787253020)ANGO
AngioDynamics, Inc.
Device clearance (510(k))
Traditional
K240397 ↗
Jul 20, 2023VenaCure EVLT NeverTouch Procedure Kits; VenaCure EVLT Neve…ANGO
AngioDynamics, Inc.
Device clearance (510(k))
Special
K231945 ↗
Mar 27, 2023Solero Microwave Tissue Ablation (MTA) System and Accessori…ANGO
AngioDynamics, Inc.
Device clearance (510(k))
Special
K223581 ↗
Mar 7, 2023Solero Microwave Tissue Ablation (MTA) System and Accessori…ANGO
AngioDynamics, Inc.
Device clearance (510(k))
Special
K221883 ↗
Apr 4, 2022AlphaVac Multipurpose Mechanical Aspiration (MMA) F1885 Sys…ANGO
AngioDynamics, Inc.
Device clearance (510(k))
Traditional
K213388 ↗
Dec 3, 2021Solero Microwave Tissue Ablation (MTA) System and Accessori…ANGO
AngioDynamics, Inc.
Device clearance (510(k))
Special
K213067 ↗
Sep 30, 2021AngioVac F18 85ANGO
AngioDynamics, Inc.
Device clearance (510(k))
Traditional
K212386 ↗
Jun 4, 2021AlphaVac Multipurpose Mechanical Aspiration (MMA) SystemANGO
AngioDynamics, Inc.
Device clearance (510(k))
Traditional
K211081 ↗
Sep 15, 2020UNIFUSE Infusion System with Cooper WireANGO
AngioDynamics, Inc.
Device clearance (510(k))
Special
K202347 ↗
Jun 1, 2020UNI*FUSE Infusion System with Cooper WireANGO
AngioDynamics, Inc.
Device clearance (510(k))
Traditional
K192864 ↗
May 22, 2020SmartPort+ Implantable Ports, SmartPort Plastic Implantable…ANGO
AngioDynamics, Inc.
Device clearance (510(k))
Traditional
K190559 ↗
Jul 5, 2019AngioVac C20, AngioVac C180ANGO
AngioDynamics, Inc.
Device clearance (510(k))
Traditional
K190594 ↗
Jun 18, 2019NanoKnife SystemANGO
Angiodynamics
Device clearance (510(k))
Traditional
K183385 ↗
Feb 28, 2019Solero MTA Cart, Solero MTA System, Solero microwave Tissue…ANGO
AngioDynamics, Inc.
Device clearance (510(k))
Traditional
K182250 ↗
Jul 18, 2018AngioDynamics, Inc. Soft-Vu and Mariner Angiographic Cathet…ANGO
AngioDynamics, Inc.
Device clearance (510(k))
Special
K173762 ↗
Jul 5, 2018400um Perforator and Accessory Vein Ablation KitANGO
AngioDynamics, Inc.
Device clearance (510(k))
Traditional
K181044 ↗
Aug 24, 2017VenaCure EVLT NeverTouch Procedure KitANGO
AngioDynamics, Inc.
Device clearance (510(k))
Traditional
K171921 ↗
Jul 19, 2017Mini Stick ENVI Non-Vascular Introducer KitANGO
AngioDynamics, Inc.
Device clearance (510(k))
Traditional
K170775 ↗
May 30, 2017VenaCure EVLT NeverTouch Direct Introducer SheathANGO
AngioDynamics, Inc.
Device clearance (510(k))
Traditional
K170695 ↗
May 30, 2017Pulse* Spray Infusion System, Uni*Fuse Infusion SystemANGO
AngioDynamics, Inc.
Device clearance (510(k))
Traditional
K163356 ↗
May 5, 2017Solero MTA System, Solero Microwave Tissue Ablation Applica…ANGO
AngioDynamics, Inc.
Device clearance (510(k))
Traditional
K162449 ↗
Apr 28, 2017Soft-Vu, Mariner, Accu-Vu and AngioOptic CathetersANGO
AngioDynamics, Inc.
Device clearance (510(k))
Traditional
K161596 ↗
Mar 30, 2017AngioDynamics Total Abscession Biliary Drainage CatheterANGO
AngioDynamics, Inc.
Device clearance (510(k))
Special
K170743 ↗
Feb 21, 2017SpeedLyser Infusion Catheter KitANGO
AngioDynamics, Inc.
Device clearance (510(k))
Special
K170258 ↗
Jan 6, 2017NAMIC ClearaCIL Contrast Injection LinesANGO
AngioDynamics, Inc.
Device clearance (510(k))
Traditional
K163141 ↗
Nov 16, 2016VenaCure EVLT NeverTouch Procedure KitANGO
AngioDynamics, Inc.
Device clearance (510(k))
Special
K162914 ↗
Oct 14, 2015AngioDynamics Mariner Angiographic CathetersANGO
AngioDynamics, Inc.
Device clearance (510(k))
Special
K151724 ↗
Jun 18, 2015NanoKnife SystemANGO
AngioDynamics, Inc.
Device clearance (510(k))
Traditional
K150089 ↗
Jan 27, 2015Celerity PICC Tip Confirmation SystemANGO
AngioDynamics, Inc.
Device clearance (510(k))
Traditional
K142889 ↗

34 items, most recent first (up to 50). Each row links to the FDA's page for the application, clearance or approval. Updated Nov 15, 2026, 7:30 PM EST.

Download CSV The rows of this feed, with the filters above. A download holds at most 10,000 rows; narrow the filters to get a smaller slice.

Other feeds: Congressional trades · Executive-branch trades · Bills in Congress · Roll-call votes · Corporate PAC donations · Lobbying · Capitol Hires · Lobbying and contracts · Government contracts · Insider trades · Planned insider sales · Executive pay · Ownership stakes (13D / 13G) · Institutional holdings (13F) · Short interest · Fails to deliver · Daily short volume · Wikipedia page views · App store ratings · H-1B visa applications · Stock splits · 8-K events · IPO filings · Deals · Private placements (Form D) · Merger clearances (HSR) · Layoff notices (WARN) · SEC enforcement · Patents · Clinical trial updates